Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
BIPIX vs UAPIX
Shared holdings
115
BIPIX covered by UAPIX
33.58%
UAPIX covered by BIPIX
33.58%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
BIPIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 28.66% | |
| Invesco Government & Agency Portfolio, Institutional Class | 1.97% | |
| APELLIS PHARMACEUTICALS INC | 1.29% | |
| REVOLUTION MEDICINES INC | 1.14% | |
| TRAVERE THERAPEUTICS INC | 1.12% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.00% | |
| TWIST BIOSCIENCE CORP | 0.99% | |
| SUMMIT THERAPEUTICS INC | 0.97% | |
| ALKERMES PLC | 0.96% | |
| TG THERAPEUTICS INC | 0.95% | |
| MADRIGAL PHARMACEUTICALS INC | 0.95% | |
| BEAM THERAPEUTICS INC | 0.92% | |
| APOGEE THERAPEUTICS INC | 0.88% | |
| SCHOLAR ROCK HOLDING CORP | 0.85% | |
| PRAXIS PRECISION MEDICINES INC | 0.85% | |
| EXELIXIS INC | 0.84% | |
| MIRUM PHARMACEUTICALS INC | 0.84% | |
| UNITED THERAPEUTICS CORP DEL | 0.83% | |
| NATERA INC | 0.83% | |
| CRISPR Therapeutics A.G. Series A | 0.83% | |
| CELCUITY INC | 0.83% | |
| KRYSTAL BIOTECH INC | 0.81% | |
| PROTAGONIST THERAPEUTICS INC | 0.81% | |
| NEUROCRINE BIOSCIENCES INC | 0.80% | |
| INCYTE CORP | 0.79% | |
| CG ONCOLOGY INC | 0.79% | |
| CYTOKINETICS INC | 0.79% | |
| NUVALENT INC-A | 0.79% | |
| IONIS PHARMACEUTICALS INC | 0.79% | |
| BRIDGEBIO PHARMA INC | 0.79% | |
| VAXCYTE INC | 0.79% | |
| KYMERA THERAPEUTICS INC | 0.79% | |
| BIOGEN INC | 0.78% | |
| COGENT BIOSCIENCES INC | 0.78% | |
| PTC THERAPEUTICS INC | 0.78% | |
| INSMED INC | 0.77% | |
| ALNYLAM PHARMACEUTICALS INC | 0.76% | |
| ROIVANT SCIENCES | 0.76% | |
| HALOZYME THERAPEUTICS INC | 0.76% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.74% | |
| SPYRE THERAPEUTICS INC | 0.74% | |
| SOLENO THERAPEUTICS INC | 0.74% | |
| ABBVIE INC | 0.73% | |
| AMGEN INC | 0.72% | |
| REGENERON PHARMACEUTICALS INC | 0.72% | |
| ULTRAGENYX PHARMA INC | 0.72% | |
| ACADIA PHARMACEUTICALS INC | 0.71% | |
| RHYTHM PHARMACEUTICALS INC | 0.71% | |
| GILEAD SCIENCES INC | 0.71% | |
| BIOMARIN PHARMACEUTICAL INC | 0.71% |
UAPIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 34.17% | |
| ZCS BRL 14.0087 05/12/25-01/04/27 CME | 1.43% | |
| BLOOM ENERGY CORP CL A | 1.22% | |
| CREDO TECHNOLOGY | 0.55% | |
| FABRINET | 0.49% | |
| COEUR MINING INC | 0.36% | |
| NEXTRACKER INC CL A | 0.34% | |
| ECHOSTAR CORP CL A | 0.33% | |
| TTM TECHNOLOGIES INC | 0.32% | |
| IONQ INC | 0.31% | |
| STERLING INFRASTRUCTURE INC | 0.30% | |
| ADV ENERGY INDS | 0.28% | |
| MODINE MFG CO | 0.26% | |
| SITIME CORP | 0.25% | |
| RAMBUS INC | 0.24% | |
| VIAVI SOLUTIONS INC | 0.24% | |
| DYCOM INDUSTRIES INC | 0.24% | |
| SANMINA CORP | 0.23% | |
| HECLA MINING CO | 0.23% | |
| KRATOS DEFENSE and SEC SOLTN INC | 0.22% | |
| BRIDGEBIO PHARMA INC | 0.22% | |
| APPLIED OPTOELECTRONICS INC | 0.21% | |
| GUARDANT HEALTH INC | 0.21% | |
| FORMFACTOR INC | 0.21% | |
| SPX TECHNOLOGIES INC | 0.21% | |
| ENSIGN GROUP INC | 0.21% | |
| PLANET LABS PBC A | 0.20% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.20% | |
| PRIMORIS SVCS CORP | 0.19% | |
| SEMTECH CORP | 0.19% | |
| CHART INDUSTRIES INC | 0.18% | |
| UMB FINANCIAL CORP | 0.18% | |
| AMERICAN HEALTHCARE REIT INC | 0.18% | |
| ARGAN INC | 0.18% | |
| CARETRUST REIT INC | 0.17% | |
| MADRIGAL PHARMACEUTICALS INC | 0.17% | |
| OKLO INC | 0.17% | |
| FIRSTCASH HOLDINGS INC | 0.17% | |
| AXSOME THERAPEUTICS INC | 0.17% | |
| FLUOR CORP | 0.17% | |
| MOOG INC-CLASS A | 0.17% | |
| LUMEN TECHNOLOGIES INC | 0.17% | |
| ESCO TECHNOLOGIES INC | 0.17% | |
| OLD NATL BANCORP | 0.16% | |
| PRAXIS PRECISION MEDICINES INC | 0.16% | |
| WATTS WATER TECH INC CL A | 0.16% | |
| VIASAT INC | 0.16% | |
| APPLIED DIGITAL CORP | 0.16% | |
| GLAUKOS CORP | 0.16% | |
| POWELL INDUSTRIES INC | 0.16% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.